SCHEMBL9925246

SCHEMBL9925246

OCc1ccsc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11420003 0.73 AKR1B1 (0.42)
SCHEMBL2690986 0.72
SCHEMBL5109989 0.72
SCHEMBL2034915 0.70
SCHEMBL3697681 0.70
SCHEMBL2981174 0.70
SCHEMBL8013847 0.70
SCHEMBL2824560 0.67 CYP2A6 (0.31)
SCHEMBL5104355 0.67 LTB4R (0.36)
SCHEMBL7366283 0.67 CYP2A6 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365540-B2 Benzimidazole derivatives as MCH receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-14 US disclosed
EP-2802571-A1 BENZIMIDAZOLE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS Takeda Pharmaceutical Company Limited (JP) 2014-11-19 EP disclosed
WO-2013105676-A1 BENZIMIDAZOLE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-07-18 WO disclosed
WO-2012075678-A1 SUBSTITUTED THIAZOLYL PYRAZOLO PYRIDINE COMPOUND AND MEDICINAL USE THEREOF 中国人民解放军军事医学科学院毒物药物研究所 (CN) 2012-06-14 WO disclosed